Familial idiopathic pulmonary fibrosis and "genetic anticipation"

C. Ravaglia, S. Tomassetti, G. Casoni, M. Romagnoli, C. Gurioli, C. Gurioli, S. Piciucchi, V. Poletti (Forlì, Italy)

Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis

Session: Genetic and molecular background in pulmonary fibrosis
Session type: Poster Discussion
Number: 1998

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Ravaglia, S. Tomassetti, G. Casoni, M. Romagnoli, C. Gurioli, C. Gurioli, S. Piciucchi, V. Poletti (Forlì, Italy). Familial idiopathic pulmonary fibrosis and "genetic anticipation". Eur Respir J 2011; 38: Suppl. 55, 1998

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Familial pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021
Familial cases of idiopathic pulmonary fibrosis: Clinical observation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Idiopathic pulmonary fibrosis Source: International Congress 2018 – State of the art session: Interstitial lung diseases Year: 2018
Idiopathic pulmonary fibrosis Source: School Course 2014 - Interstitial lung diseases Year: 2014
Idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2015; 68: 50-63 Year: 2015
Idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2013; 62: 37-53 Year: 2013
Exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016
PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021
Pulmonary fibrosis: “idiopathic” is not “cryptogenic” Source: Eur Respir J, 53 (3) 1900400; 10.1183/13993003.00400-2019 Year: 2019
Pulmonary fibrosis: “idiopathic” is not “cryptogenic” Source: Eur Respir J, 53 (3) 1802314; 10.1183/13993003.02314-2018 Year: 2019
Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016
Pathogenesis of pulmonary fibrosis in sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020
Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013
Pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013
Genetics in idiopathic pulmonary fibrosis Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine Year: 2016
Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015
Immunogenetic background of children´s idiopathic interstitial pneumonias and adult idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Severe idiopathic pulmonary fibrosis: what can be done? Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017 Year: 2017